A Randomized Trial of Deep Neuromuscular Blockade Reversed With Sugammadex Versus Moderate Neuromuscular Block Reversed With Neostigmine, on Postoperative Quality of Recovery
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms DEEPBLOCK
- 17 Jun 2017 Status changed from not yet recruiting to recruiting.
- 26 May 2017 Planned initiation date changed from 30 Mar 2017 to 3 Jun 2017.
- 03 Feb 2017 New trial record